Advanced search
Publication Cover
Therapeutic Delivery Volume 3, 2012 - Issue 9
Submit an article Journal homepage
1,403
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Inhaled Chemotherapy in Lung Cancer: Safety Concerns of Nanocomplexes Delivered

Paul Zarogoulidisa Pulmonary Department G Papanikolaou General Hospital Aristotle University of [email protected]
,
Chrisostomi Gialelib Laboratory of Biochemistry Department of Chemistry University of Patras Greece and Foundation for Research & Technology – Hellas/Institute of Chemical Engineering SciencesGreece
&
Nikos K Karamanosc Laboratory of Biochemistry Department of Chemistry University of Patras Greece and Foundation for Research and Technology – Hellas/Institute of Chemical Engineering SciencesGreece
Pages 1021-1023 | Published online: 29 Aug 2012

References

  • Maynard AD . Don‘t define nanomaterials. Nature475(7354), 31 (2011).
  • US FDA. Reporting Format for Nanotechnology-Related Information in CMC Review. Office of Pharmaceutical Science, Silver Spring, MD, USA (2010).
  • Bawarski WE , ChidlowskyE, BharaliDJ, MousaSA. Emerging nanopharmaceuticals. Nanomedicine4(4), 273–282 (2008).
  • Brouwer N , WedaM, van Riet-Nales D, de Kaste D. Nanopharmaceuticals: implications for the European pharmacopoeia. Pharmeuropa22, 5–7 (2010).
  • Zhang L , GuFX, ChanJM, WangAZ, LangerRS, FarokhzadOC. Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther.83(5), 761–769 (2008).
  • Zarogoulidis P , PapanasN, KouliatsisG, SpyratosD, ZarogoulidisK, MaltezosE. Inhaled insulin: too soon to be forgotten? J. Aerosol Med. Pulm. Drug Deliv.24(5), 213–223 (2011).
  • Zarogoulidis P , EleftheriadouE, SapardanisIet al. Feasibility and effectiveness of inhaled carboplatin in NSCLC patients. Invest. New Drugs 30(4), 1628–1640 (2011).
  • Lebhardt T , RoeslerS, UusitaloHP, KisselT. Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation. Eur. J. Pharm. Biopharm.78(1), 90–96 (2011).
  • Taratula O , GarbuzenkoOB, ChenAM, MinkoT. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. J. Drug Target.19(10), 900–914 (2011).
  • Yang W , PetersJI, WilliamsRO III. Inhaled nanoparticles – a current review. Int. J. Pharm.356(1–2), 239–247 (2008).
  • Tseng CL , SuWY, YenKC, YangKC, LinFH. The use of biotinylated EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials30(20), 3476–3485 (2009).
  • Tatsumura T , KoyamaS, TsujimotoM, KitagawaM, KagamimoriS. Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical. Br. J. Cancer68(6), 1146–1149 (1993).
  • Gautam A , KoshkinaN. Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery. Curr. Cancer Drug Targets3(4), 287–296 (2003).
  • Otterson GA , Villalona-CaleroMA, HicksWet al. Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer. Clin. Cancer Res. 16(8), 2466–2473 (2010).
  • Wittgen BP , KunstPW, PerkinsWR, LeeJK, PostmusPE. Assessing a system to capture stray aerosol during inhalation of nebulized liposomal cisplatin. J. Aerosol Med.19(3), 385–391 (2006).
  • Anderson K , LawsonKA, Simmons-MenchacaM, SunL, SandersBG, KlineK. Alpha-TEA plus cisplatin reduces human cisplatin-resistant ovarian cancer cell tumor burden and metastasis. Exp. Biol. Med. (Maywood)229(11), 1169–1176 (2004).
  • El -Gendy N, Berkland C. Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration. Pharm. Res.26(7), 1752–1763 (2009).
  • Zarogoulidis P , ChatzakiE, PorpodisKet al. Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int. J. Nanomed. 7, 1551–1572 (2012).
  • Labiris NR , DolovichMB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br. J. Clin. Pharmacol.56(6), 588–599 (2003).
  • Margaris KN , BlackRA. Modelling the lymphatic system: challenges and opportunities. J. R. Soc. Interface9(69), 601–612 (2012).
  • Selting K , WaldrepJC, ReineroCet al. Feasibility and safety of targeted cisplatin delivery to a select lung lobe in dogs via the AeroProbe intracorporeal nebulization catheter. J. Aerosol Med. Pulm. Drug Deliv. 21(3), 255–268 (2008).
  • Bosquillon C . Drug transporters in the lung – do they play a role in the biopharmaceutics of inhaled drugs? J. Pharm. Sci.99(5), 2240–2255 (2010).
  • Minchinton AI , TannockIF. Drug penetration in solid tumours. Nat. Rev. Cancer6(8), 583–592 (2006).
  • Zhang J , WuL, ChanHK, WatanabeW. Formation, characterization, and fate of inhaled drug nanoparticles. Adv. Drug Deliv. Rev.63(6), 441–455 (2011).
  • Arora S , RajwadeJM, PaknikarKM. Nanotoxicology and in vitro studies: the need of the hour. Toxicol. Appl. Pharmacol.258(2), 151–165 (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.